Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy

被引:0
作者
Young-Joon Kang
Wonshik Han
Soojin Park
Ji Young You
Ha Woo Yi
Sungmin Park
Sanggeun Nam
Joo Heung Kim
Keong Won Yun
Hee Jeong Kim
Sei Hyun Ahn
Seho Park
Jeong Eon Lee
Eun Sook Lee
Dong-Young Noh
Jong Won Lee
机构
[1] Seoul National University College of Medicine,Department of Surgery
[2] Research Institute and Hospital,Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation
[3] National Cancer Center,Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center
[4] Sungkyunkwan University School of Medicine,Department of Surgery
[5] Yonsei University College of Medicine,Department of Surgery
[6] University of Ulsan College of Medicine,undefined
[7] Asan Medical Center,undefined
来源
Breast Cancer Research and Treatment | 2017年 / 166卷
关键词
Breast cancer; Sentinel lymph node biopsy; Axillary lymph node dissection; Neoadjuvant chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:473 / 480
页数:7
相关论文
共 304 条
[1]  
Schwartz GF(2002)Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania Cancer 94 2542-2551
[2]  
Giuliano AE(2007)Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 881-888
[3]  
Veronesi U(1999)Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy Ann Surg 230 72-78
[4]  
Consensus Conference C(2012)Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial Lancet 379 633-640
[5]  
Krag DN(2015)Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy Nat Rev Clin Oncol 12 335-343
[6]  
Anderson SJ(2013)Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JAMA 310 1455-1461
[7]  
Julian TB(2013)Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study Lancet Oncol 14 609-618
[8]  
Brown AM(2002)Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement Radiology 225 527-536
[9]  
Harlow SP(2009)Magnetic resonance imaging for axillary staging in patients with breast cancer J Magn Reson Imaging 30 309-312
[10]  
Ashikaga T(2012)Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging Ann Surg Oncol 19 1825-1830